Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Perspective Therapeutics, Inc.Perspective Therapeutics Reports Significant Financial Growth and Cash Flow Improvement
Nuwellis, Inc.Nuwellis Reports Improved Financials, Net Income Turnaround in Q3 2024
Rhinebeck Bancorp, Inc.Rhinebeck Bancorp Reports Net Loss of $8.1M in Q3 2024, Net Loss of $6.0M for Nine Months
Kodiak AI, Inc.Ares Acquisition Corporation II Reports Net Income Growth, Doubts on Going Concern
NORTHWEST BIOTHERAPEUTICS INCNorthwest Biotherapeutics Reports Significant Revenue Growth, But Continues to Face Financial Challenges
iANTHUS CAPITAL HOLDINGS, INC.iAnthus Capital Holdings Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024
Electromed, Inc.Electromed, Inc. Reports 19% Revenue Growth and Improved Profitability in Q3 2024
PSYCHEMEDICS CORPPsychemedics Reports 9% Revenue Decline, Reduces Operating Expenses, and Plans Reverse/Forward Stock Split
TERAWULF INC.TeraWulf Reports Revenue Growth, Net Loss in Latest Quarter
Pioneer Bancorp, Inc./MDPioneer Bancorp Reports Strong Financial Growth and Strategic Progress in Q3 2024
PowerFleet, Inc.PowerFleet Reports 124.9% Revenue Growth in Q3 2024, Net Loss Despite MiX Telematics Acquisition
LISATA THERAPEUTICS, INC.Lisata Therapeutics Reports Third Quarter and Nine Months Financial Results, Focuses on Clinical Development Efforts
RUM Group Inc.Rumble Inc. Reports Revenue Growth, Narrowing Losses in Q3 2024
KYNTRA BIO, INC.FibroGen Reports 15% Revenue Growth, Improved Net Loss in Q3 2024
CXApp Inc.CXApp Inc. Reports Mixed Financial Results, Widening Net Loss Despite Revenue Growth
MARINUS PHARMACEUTICALS, INC.Marinus Pharmaceuticals Reports Revenue Growth, Net Loss, and Significant Financial Changes in Q3 2024
DYADIC INTERNATIONAL INCDyadic International Reports Significant Revenue Growth, Improved Profitability in Q3 2024
Atara Biotherapeutics, Inc.Atara Biotherapeutics Reports Significant Revenue Growth, Net Loss Reduction in Q3 2024
Lionsgate Studios Corp.Lionsgate Studios Reports Mixed Financial Results, Net Loss Amid Revenue Growth
MARIN SOFTWARE INCMarin Software Reports Mixed Q3 Results, Declining Revenues but Improved Gross Profit Margins
Artiva Biotherapeutics, Inc.Artiva Biotherapeutics Reports Significant Financial Developments, Including Increased Assets and Net Loss
COLOMBIER ACQUISITION CORP. IIColombier Acquisition Corp. II Reports Financial Performance Following IPO, Net Income Turnaround
Prime Medicine, Inc.Prime Medicine Reports Strong Financials, Collaboration Revenue Growth, and Strategic Partnerships in Latest 10-Q Filing
CARGO Therapeutics, Inc.Cargo Therapeutics Reports Significant Financial Developments, Including Decrease in Cash Reserves and Increased Losses
Insight Molecular Diagnostics Inc.Oncocyte Corporation Reports Significant Financial Challenges in Latest 10-Q Filing